Field Medical Names Mark A. Turco, MD, as Chief Executive Officer

Field Medical, Inc. California

for its ventricular tachycardia indication. In October 2025, the VCAS trial was published in Circulation.

For more information, visit www.fieldmedicalinc.com and follow us on LinkedIn, X, and YouTube.

The FieldForce™ Ablation System is an investigational device and is limited by federal (or United States) law to investigational use.

Media Contact
Holly Windler
619.929.1275
[e-mail]

Photo - https://mma.prnewswire.com/media/2933749/Field_Medical_new_CEO_Dr_Mark_A_Turco.jpg

Logo - https://mma.prnewswire.com/media/2574173/Field_Medical_Logo_Block_WhiteOnBlack_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/field-medical-names-mark-a-turco-md-as-chief-executive-officer-302713815.html